HighTower Advisors LLC increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 45,601 shares of the biotechnology company’s stock after buying an additional 1,997 shares during the period. HighTower Advisors LLC’s holdings in Axon Enterprise were worth $32,726,000 at the end of the most recent reporting period.
Several other institutional investors have also recently bought and sold shares of AXON. Vanguard Group Inc. grew its position in shares of Axon Enterprise by 3.5% in the second quarter. Vanguard Group Inc. now owns 8,937,260 shares of the biotechnology company’s stock valued at $7,399,515,000 after purchasing an additional 305,252 shares during the last quarter. Geode Capital Management LLC grew its holdings in Axon Enterprise by 5.9% in the 2nd quarter. Geode Capital Management LLC now owns 2,072,186 shares of the biotechnology company’s stock valued at $1,713,332,000 after buying an additional 115,349 shares during the last quarter. Jennison Associates LLC increased its position in Axon Enterprise by 53.8% in the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock worth $677,412,000 after buying an additional 330,213 shares during the period. Vestor Capital LLC lifted its holdings in shares of Axon Enterprise by 438,636.3% during the second quarter. Vestor Capital LLC now owns 833,599 shares of the biotechnology company’s stock worth $690,170,000 after buying an additional 833,409 shares during the last quarter. Finally, Norges Bank bought a new stake in shares of Axon Enterprise in the second quarter valued at approximately $637,806,000. Institutional investors own 79.08% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts recently issued reports on the stock. UBS Group dropped their target price on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research report on Wednesday, November 5th. Piper Sandler dropped their price objective on shares of Axon Enterprise from $893.00 to $753.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th. Wall Street Zen cut shares of Axon Enterprise from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Morgan Stanley decreased their target price on Axon Enterprise from $760.00 to $713.00 and set an “overweight” rating on the stock in a research report on Wednesday, December 17th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a report on Monday, December 29th. Fifteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $805.71.
Insider Activity at Axon Enterprise
In other news, CAO Jennifer H. Mak sold 1,134 shares of the business’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $600.00, for a total value of $680,400.00. Following the sale, the chief accounting officer owned 13,740 shares in the company, valued at approximately $8,244,000. The trade was a 7.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brittany Bagley sold 2,000 shares of the stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $580.00, for a total transaction of $1,160,000.00. Following the sale, the chief financial officer owned 103,501 shares of the company’s stock, valued at $60,030,580. This trade represents a 1.90% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 48,040 shares of company stock valued at $27,249,338. Insiders own 4.40% of the company’s stock.
Axon Enterprise Trading Down 0.4%
Shares of AXON opened at $430.12 on Thursday. The stock has a 50 day simple moving average of $550.04 and a 200-day simple moving average of $641.48. The company has a current ratio of 3.12, a quick ratio of 2.89 and a debt-to-equity ratio of 0.57. The stock has a market cap of $33.94 billion, a PE ratio of 136.11, a PEG ratio of 13.01 and a beta of 1.48. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
